Clinical Trials in Houston

Showing 961-980 of 8,625 trials

Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas

NCT07102966

The purpose of this study is to provide advanced genetic testing and virtual consultations for seriously ill newborns in hospitals in Texas with fewer resources, especially along the Texas-Mexico border. The researchers also want to know how well the virtual consultation tool, called Consultagene, works in these hospitals by gathering feedback from healthcare providers. Researchers will provide rapid whole genome sequencing (WGS) to 200 infants over a period of 5 years. Data will be collected via Consultagene, surveys, and qualitative interviews.

Rare Diseases

Baylor College of Medicine410 participantsStarted Oct 2025

Houston, Texas, United States

RECRUITINGNA< 1 mile

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

NCT05839730

FIRE-HFpEF is a multi-center, prospective, randomized, single-blinded, clinical feasibility study. This study will enroll up to 105 subjects with heart failure with preserved ejection fraction in the United States. Data will be collected to evaluate whether pacing therapies can lead to improvements in exercise capacity and health status of subjects.

Heart Failure With Preserved Ejection FractionConcentric Hypertrophy

Medtronic Cardiac Rhythm and Heart Failure105 participantsStarted Sep 2024

Naples, Florida, United States • O'Fallon, Illinois, United States • Springfield, Illinois, United States +6 more locations

Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction

Find Trials by Condition in Houston

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Sex-specific Determinants of Early-phase Recovery From Skeletal Muscle Disuse

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Vaccine Immune Recovery After Leukemia

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours